May 5, 2012
Medical Marijuana Resource Site Doobons.com Partners with Idrasil to Deliver First Full-Spectrum Medicinal Cannabis Pill in Measured Dosages
Idrasil, a full-spectrum cannabinoid pill, satisfies the medical community with its standardized 25 mg tablet.
San Francisco, CA (PRWEB) May 05, 2012
Idrasil´s standardized formula delivers a consistent potency and arms patients with the ability to medicate themselves and achieve the same results every time–just like any other standardized pharmaceutical.
Manufactured in a laboratory with 1:1:1 ratio of all natural CBD, CBN and THC, Idrasil is a tablet that allows patients a new option for cannabinoid therapy. Idrasil is currently available in California with a doctors´ recommendation (click here for a list of doctors who make Idrasil recommendations).
Idrasil, a product of C3 Patients Association, can be used to treat a variety of ailments and conditions such as AIDS and wasting syndrome, cancer, fibromyalgia, Crohn´s disease, Alzheimer´s disease, glaucoma, chronic pain, MS, Parkinson´s disease, sleep disorders, anxiety and depression. It can also be useful for treating chemical dependency and withdrawal symptoms.
For pain patients who have not yet been introduced to opiates, Idrasil is an excellent first step to pain abatement. The use of cannabinoids eliminate the risks of opioid overdose, an important concern to all caregivers and their liable parties. Cannabis-based medications are also not addictive like opioids.
“Until now, medications like Marinol are made from synthetic tetrahydrocannabinol (THC),” said John at Doobons.com. “Idrasil contains the full spectrum of phytocannabinoids, which is more effective than THC alone and can significantly reduce many symptoms associated with many serious illnesses.”
Phytocannabinoids are the naturally occurring cannabinoids present in cannabis. The most prevalent of these are THC, Cannabidiol (CBD) and Cannabinol (CBN), but there are actually over 85 phytocannabinoids present in cannabis, and many of these have known medicinal qualities, according to Idrasil.
Idrasil carefully extracts the full-spectrum of phytocannabinoids using a proprietary technology that does not involve the use of oils, chemicals or other additives. The extract is then carefully measured into tablets, so every pill delivers the same amount of medication.
The benefits of Idrasil include:
1. No Smoking
2. Standardized 25mg tablets
3. Aseptically Processed and Bacteria Free
4. Consistent, Proprietary “Clone-Only” Formula
6. Reimbursable by Most Insurance Plans
Not only does Idrasil deliver consistent results, it is a more discreet option which eliminates any negative social stigmas of smoking marijuana.
Doobons.com was designed to make medical marijuana convenient and approachable to everyone, including those who are new to the world of medical cannabis. While most of today´s online medical cannabis directories are designed for patients who already know at least something about using medical cannabis, Doobons.com is designed to be user friendly for patients of all ages and experience levels.
Doobons.com is more than just another online medical marijuana directory. The site´s News, Resource, and Blog pages provide valuable information and advice for patients and caregivers. The information posted helps new patients learn about the ins and outs of the world of medical cannabis, and existing patients stay abreast of developments.
For more information about Doobons.com, call (415) 524-8099 or go to Doobons.com online. The best way to stay informed about developments on Doobons.com is to "like" them on Facebook at http://www.facebook.com/pages/DOOBONSCOM/211376972233726 and "follow" them on Twitter @DOOBONS.
The five-star-rated Doobons iPhone app is now available for free on the iTunes app store for iPhone 3GS, iPhone 4, iPhone 4S, iPod touch (3rd generation), iPod touch (4th generation) and iPad that runs on iOS 4.3 or later.
For more information about Doobons.com, call (415) 524-8099 or go to Doobons.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb-medical-marijuana/-information-san-francisc/prweb9477599.htm